HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yang, C.-y. Articles by Smith, C. V. Search for Related Content PubMed PubMed Citation Articles by Yang, C.-y. Articles by Smith, C. V. Social Bookmarking                      What's this?

The Journal of Lipid Research, Vol. 40, 686-698, April 1999
Copyright © 1999 by Lipid Research, Inc.

Original Article

Selective modification of apoB-100 in the oxidation of low density lipoproteins by myeloperoxidase in vitro

Correspondence to: Chao-yuh Yang

Oxidative modification of LDL may be important in the initiation and/or progression of atherosclerosis, but the precise mechanisms through which low density lipoprotein (LDL) is oxidized are unknown. Recently, evidence for the existence of HOCl-oxidized LDL in human atherosclerotic lesions has been reported, and myeloperoxidase (MPO), which is thought to act through production of HOCl, has been identified in human atherosclerotic lesions. In the present report we describe the formation of 2,4-dinitrophenylhydrazine (DNPH)-reactive modifications in the apolipoprotein (apo) by exposure of LDL to myeloperoxidase in vitro. In contrast with the complex mixture of peptides from oxidation of LDL with reagent HOCl, oxidation with MPO in vitro produced a major tryptic peptide showing absorbance at 365 nm. This peptide was isolated and characterized as VELEVPQL(*C)SFILK ... , corresponding to amino acid residues 53– 66 ... on apoB-100. Mass spectrometric analyses of two tryptic peptides from oxidation of LDL by HOCl indicated formation of the corresponding methionine sulfoxide (M=O), cysteinyl azo (*C), RS –N= N–DNP, derivatives of EEL(*C)T(M=O)FIR and LNDLNS VLV(M=O)PTFHVPFTDLQVPS(*C)K, which suggest oxidation to the corresponding sulfinic acids (RSO₂H) by HOCl.

The present results demonstrate that DNPH-reactive modifications other than aldehydes and ketones can be formed in the oxidation of proteins and illustrate how characterization of specific products of protein oxidation can be useful in assessing the relative contributions of different and unexpected mechanisms to the oxidation of LDL and other target substrates. The data also suggest a direct interaction of the LDL particle with the active site on myeloperoxidase and indicate that effects of the protein microenvironment can greatly influence product formation and stability.—Yang, C-y., Z-W. Gu, M. Yang, S-N. Lin, A. J. Garcia-Prats, L. K. Rogers, S. E. Welty, and C. V. Smith. Selective modification of apoB-100 in the oxidation of low density lipoproteins by myeloperoxidase. J. Lipid Res. 1999. 40: 686 – 698.

Supplementary key words: myeloperoxidase, HOCl, hypochlorous acid, LDL, low density lipoproteins, oxidized LDL peptides, 2,4-dinitrophenylhydrazine, apoB-100

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. J. Klebanoff Myeloperoxidase: friend and foe J. Leukoc. Biol., May 1, 2005; 77(5): 598 - 625. [Abstract] [Full Text] [PDF]

				R. Stocker and J. F. Keaney Jr. Role of Oxidative Modifications in Atherosclerosis Physiol Rev, October 1, 2004; 84(4): 1381 - 1478. [Abstract] [Full Text] [PDF]

				Y.-M. Go, A.-L. Levonen, D. Moellering, A. Ramachandran, R. P. Patel, H. Jo, and V. M. Darley-Usmar Endothelial NOS-dependent activation of c-Jun NH2- terminal kinase by oxidized low-density lipoprotein Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2705 - H2713. [Abstract] [Full Text] [PDF]

				R. Zhang, M.-L. Brennan, X. Fu, R. J. Aviles, G. L. Pearce, M. S. Penn, E. J. Topol, D. L. Sprecher, and S. L. Hazen Association Between Myeloperoxidase Levels and Risk of Coronary Artery Disease JAMA, November 7, 2001; 286(17): 2136 - 2142. [Abstract] [Full Text] [PDF]

				C.-y. Yang, J. Wang, A. N. Krutchinsky, B. T. Chait, J. D. Morrisett, and C. V. Smith Selective oxidation in vitro by myeloperoxidase of the N-terminal amine in apolipoprotein B-100 J. Lipid Res., November 1, 2001; 42(11): 1891 - 1896. [Abstract] [Full Text] [PDF]

				C. Zhang, R. Patel, J. P. Eiserich, F. Zhou, S. Kelpke, W. Ma, D. A. Parks, V. Darley-Usmar, and C. R. White Endothelial dysfunction is induced by proinflammatory oxidant hypochlorous acid Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1469 - H1475. [Abstract] [Full Text] [PDF]

				P. L. RAMSAY, F. J. DeMAYO, S. E. HEGEMIER, M. E. WEARDEN, C. V. SMITH, and S. E. WELTY Clara Cell Secretory Protein Oxidation and Expression in Premature Infants Who Develop Bronchopulmonary Dysplasia Am. J. Respir. Crit. Care Med., July 1, 2001; 164(1): 155 - 161. [Abstract] [Full Text] [PDF]

				A. C. Carr, M. R. McCall, and B. Frei Oxidation of LDL by Myeloperoxidase and Reactive Nitrogen Species : Reaction Pathways and Antioxidant Protection Arterioscler. Thromb. Vasc. Biol., July 1, 2000; 20(7): 1716 - 1723. [Abstract] [Full Text] [PDF]